Kellyanne Conway called him a “man of action” after a whirlwind first week in which President Trump signed 14 Executive Orders and presidential memoranda, covering most of his key campaign issue areas from health to immigration to trade. In a series of blogs, CGD experts have been examining how some of these specific policy intentions could impact development progress. As you would expect from a group of economists, we believe in—and encourage—evidence-based policymaking, and here we look at what the existing evidence and research tell us about how likely these Executive Orders are to achieve the president’s stated goals.
CGD Policy Blogs
In 2007, the World Bank established the multi-donor Health Results Innovation Trust Fund (HRITF) to support and evaluate low-income country government efforts to pay providers based on their results in health care, with a focus on reproductive, maternal, newborn, child and adolescent health and nutrition. A decade later, the HRITF has had substantial impact on how governments and aid partners think and talk about health care financing, and the term “results-based financing” or RBF is now well-established in the policy vernacular.
Empowering Women Can Make America Great – Podcast with Amanda Glassman, Mayra Buvinic, and Charles Kenny
The scale of the turnout at the Women’s Marches across the world recently, along with President Trump’s early reinstatement of a ban on US funding for organizations that offer family planning services in foreign countries, seem to suggest an administration already at odds with an entire gender. On this week’s podcast, three CGD senior fellows weigh in on the evidence that engaging and empowering women—both at home and overseas—makes good sense, especially in an America-First strategy.
On his first day in the office, President Trump signed an executive order reinstating a 30-year-old political hot potato, the “Mexico City Policy." Like many, I will point out that reinstating the global gag rule does not reduce abortion.
I’m very pleased to announce the addition of Stephen T Isaacs to the Center for Global Development’s Board of Directors. Steve has been a leader in the biomedical field for over 30 years, founding companies that focus on developing novel, innovative immunotherapies and vaccines for cancer and infectious diseases. He is the Chairman, Director, President, and Chief Executive Officer of Aduro Biotech.